Trial · NCT02750514
Adverse event totals39
The totals the trial posted for each group.
1 to 20 of 39
Download this page as JSON| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Track 1 - Nivolumab | 22 | 40 |
| Total, all-cause mortality | Track 1 - Nivolumab + Dasatinib | 2 | 4 |
| Total, all-cause mortality | Track 1 - Nivolumab + Ipilimumab | 1 | 3 |
| Total, all-cause mortality | Track 2 - Nivolumab | 6 | 9 |
| Total, all-cause mortality | Track 2 - Nivolumab + Dasatinib | 4 | 8 |
| Total, all-cause mortality | Track 2 - Nivolumab + BMS986016 | 2 | 2 |
| Total, all-cause mortality | Track 2 - Nivolumab + Ipilimumab | 6 | 12 |
| Total, all-cause mortality | Track 3 - Nivolumab + Dasatinib | 20 | 41 |
| Total, all-cause mortality | Track 3 - Nivolumab + BMS986016 | 10 | 16 |
| Total, all-cause mortality | Track 3 - Nivolumab + Ipilimumab | 9 | 18 |
| Total, all-cause mortality | Track 4 - Nivolumab + Dasatinib | 33 | 53 |
| Total, all-cause mortality | Track 4 - Nivolumab + Ipilimumab | 27 | 60 |
| Total, all-cause mortality | Track 5 - Nivolumab + BMS986205 | 27 | 43 |
| Total, other adverse events | Track 1 - Nivolumab | 38 | 40 |
| Total, other adverse events | Track 1 - Nivolumab + Dasatinib | 4 | 4 |
| Total, other adverse events | Track 1 - Nivolumab + Ipilimumab | 3 | 3 |
| Total, other adverse events | Track 2 - Nivolumab | 9 | 9 |
| Total, other adverse events | Track 2 - Nivolumab + Dasatinib | 7 | 8 |
| Total, other adverse events | Track 2 - Nivolumab + BMS986016 | 2 | 2 |
| Total, other adverse events | Track 2 - Nivolumab + Ipilimumab | 12 | 12 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02750514/event-totals